Document is current

Any future updates will be listed below

Targeted Delivery of Combination Therapeutics Using Monoclonal Antibody 2C5-Modified Immunoliposomes for Cancer Therapy

Crossref DOI link: https://doi.org/10.1007/s11095-021-02986-1

Published Online: 2021-03-02

Published Print: 2021-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark